Transcript of the closed two-day June 7-8, 2000 meeting at the Simpsonwood Retreat Center, Norcross, GA, convened to review Thomas Verstraeten's first-phase VSD analysis of thimerosal exposure and neurodevelopmental outcomes. The transcript documents genuine scientific concern about a possible dose-response signal, explicit discussion of study limitations, and debate over communication and further analysis. Critics read it as evidence of suppression; the published follow-up analyses (MMD-09) and the IOM (MMD-10) reported no consistent association.
Analysis to date raise some concerns of a possible dose-response effect of increasing levels of methylmercury [sic] in vaccines and certain neurologic diagnoses. Therefore, the purpose of this meeting is to have a careful scientific review of the data. This is not a policy making meeting.
Transcript, opening remarks (Walter Orenstein), day 1
Transcript of the closed two-day June 7-8, 2000 meeting at the Simpsonwood Retreat Center, Norcross, GA, convened to review Thomas Verstraeten's first-phase VSD analysis of thimerosal exposure and neurodevelopmental outcomes. The transcript documents genuine scientific concern about a possible dose-response signal, explicit discussion of study limitations, and debate over communication and further analysis. Critics read it as evidence of suppression; the published follow-up analyses (MMD-09) and the IOM (MMD-10) reported no consistent association.